CF Tech is proud to release separation and purification details on our Lutitium-177 radioisotope purification development. This technology is a fast, safe and inexpensive method for separation of the product from the irradiated target to be used in cancer therapy. After the irradiation, the target passes through a single chromatographic column and the highly pure product of interest, Lutitium-177 is collected. The product undergoes analysis and can be directly processed. CF Tech's technology is patent pending. Process and analysis details are included in our White Paper - available for download - for review and comment. This research was sponsored by the US Department of Energy with partners at the Idaho National Laboratory and was performed at CF Tech and at the Massachusetts Institute of Technologies' Nuclear Reactor Lab.  High Purity Lutitium-177
0 Comments
Leave a Reply. |
Jessica Sweeney"All Around CF Tech-er" Archives
October 2023
Categories
All
|
||||
RSS Feed